Arrow Financial Corporation reports Q1 results on June 3 with the lending market offering virtually no friction for short sellers — yet few have shown up to use it.
The borrow side of the story is conspicuously easy. Availability runs at over 3,600% of short interest, meaning the lending pool dwarfs the position that would need to be covered. Cost to borrow has eased to 0.47%, down roughly 27% over the past week alone. Short interest itself is only 1.4% of the free float — a modest level, though it has crept up about 9.5% over the past week. The ORTEX short score of 31.5 sits well below stress territory. Together, these readings describe a stock that short sellers are edging into incrementally, not aggressively targeting. Peers including FBIZ, THFF, and SHBI all posted small gains on the week, while AROW dipped 1.2% — a modest underperformance, but not one that screams a structural shift.
The debate heading into the print centres on margin recovery versus fee pressure. Bulls can point to a 23-basis-point expansion in net interest margin to 3.08%, driven by balance-sheet restructuring and rate positioning — a genuine positive for a community bank that lives on the spread. Total deposits grew 3.7% on a seasonal basis, adding to the funding-side comfort. Bears focus on what isn't working: core fees fell 6% quarter-over-quarter and missed expectations by $0.03 per share, while non-interest-bearing deposits nudged lower, representing roughly 18% of total deposits. A seasonal deposit drawdown is also expected in the current quarter, which could restrain the NIM tailwind. The sole analyst on record — Piper Sandler's Frank Schiraldi, who last moved the target over a year ago to $28 — is well below the current price of $36.39. That gap raises consistency questions about the target's relevance, and the data is too stale to carry weight here. The mean price target of $38 implies modest upside but comes with limited coverage.
Insider activity adds a quiet note of confidence. CEO David DeMarco bought just over 3,000 shares at $31.78 in late December, a $96,000 commitment that came as the stock traded well below current levels. Since then, net insider activity over the past 90 days has been minimal — a handful of small director accumulations totalling roughly $2,000. No insiders have been selling at these higher prices, which is at least a neutral signal. The ORTEX stock score of 77.6 is near a six-month high, with growth as the standout pillar, reflecting what appears to be a recent upward earnings revision. The dividend score ranks in the 84th percentile, consistent with Arrow's long-standing identity as a conservative yield-oriented franchise.
Past earnings reactions have been mixed in direction but reliably small in magnitude — prior prints produced one-day moves ranging from less than 1% to roughly 4.5%. The June 3 release tests whether the NIM improvement is durable enough to offset softening fee income, and whether management's guidance on deposit seasonality reassures or unnerves a market that has already given the stock a 14% lift from December's lows.
See the live data behind this article on ORTEX.
Open AROW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
